The Supreme Court of India has granted significant relief to yoga guru Baba Ramdev and Patanjali Ayurved by deciding to close the case filed against them by the Indian Medical Association (IMA). The IMA had approached the court alleging that Patanjali issued misleading advertisements targeting allopathy. However, the bench observed that the primary purpose of the petition had already been fulfilled through multiple previous court orders, making further proceedings unnecessary.

Bench Decides No Further Action Needed

The case was heard by a bench comprising Justice BV Nagarathna and Justice KV Viswanathan. The judges noted that the court had already passed several orders addressing the matter, and therefore, the objective of the litigation was accomplished. Consequently, they ruled that there was no further need to continue the case. The court clarified that if any fresh issues arise in the future, the concerned parties are free to approach the High Court.

Earlier Contempt Proceedings Dropped

In February last year, the Supreme Court had initiated contempt proceedings against Baba Ramdev and Acharya Balkrishna for allegedly violating court orders in connection with their advertisements. However, in August of the same year, the court dropped the proceedings after both Ramdev and Balkrishna offered an unconditional apology. This paved the way for a settlement of the dispute, and the matter was subsequently put to rest.

Background of the Dispute with IMA

The IMA’s petition was based on allegations that Patanjali ran advertisements that undermined modern medicine and promoted its products in a misleading manner. The association claimed such ads misled the public and damaged the reputation of allopathic medical practice. The Supreme Court had previously taken note of the matter and issued directions to prevent such practices.

Delhi High Court’s Interim Order in Dabur Case

While the Supreme Court case against Patanjali has now been closed, the company recently faced another legal setback in a separate matter. In July, the Delhi High Court issued an interim order against Patanjali in connection with a dispute raised by Dabur India over Chyawanprash advertisements. Dabur alleged that Patanjali had aired derogatory commercials against Dabur Chyawanprash in both print and television formats.

Justice Mini Pushkarna, presiding over the case, stated that the material presented by Dabur indicated a clear prima facie case of disparagement. The court restrained Patanjali from running the contested advertisements and directed specific modifications.

Court’s Directions on Advertisement Modifications

The Delhi High Court ordered Patanjali to remove the phrase “Why be satisfied with ordinary Chyawanprash made from 40 herbs?” from its print ads. For television commercials, the court instructed that the line questioning the knowledge of Ayurveda or Vedic tradition in making authentic Chyawanprash be removed. Furthermore, the concluding line “So why ordinary Chyawanprash” was also to be deleted. Only after making these changes would Patanjali be permitted to run the revised advertisements.

Implications of the Supreme Court’s Closure of the IMA Case

The Supreme Court’s decision to close the IMA case brings an end to a long-standing legal battle that had placed Patanjali under the scanner for its marketing practices. The ruling can be seen as a relief for the company, as it eliminates ongoing litigation at the apex court level. However, the company still needs to navigate ongoing disputes in other courts, such as the Dabur case, where allegations of disparaging competitor products are yet to be fully resolved.

The order also underscores the Supreme Court’s stance that once the objectives of a public interest petition are achieved, continuing the proceedings serves no purpose. By granting liberty to approach the High Court for future grievances, the court has kept the door open for legal remedies while preventing unnecessary prolongation of cases.

Looking Ahead for Patanjali

With the closure of the Supreme Court matter, Patanjali can focus on compliance with advertising regulations and ensuring that its promotional strategies do not violate competitive or consumer protection laws. The company continues to enjoy a significant presence in India’s FMCG and Ayurveda markets, and legal clarity in such high-profile cases is crucial for its public image and business growth.